(3S,4S)-TofacitinibCAS# 1092578-47-6 |
Related Products
- Pyridostatin
Catalog No.:BCC1875
CAS No.:1085412-37-8
- 360A iodide
Catalog No.:BCC1308
CAS No.:737763-37-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1092578-47-6 | SDF | Download SDF |
| PubChem ID | 20111936 | Appearance | Powder |
| Formula | C16H20N6O | M.Wt | 312.37 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : ≥ 100 mg/mL (320.13 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | 3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile | ||
| SMILES | CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N | ||
| Standard InChIKey | UJLAWZDWDVHWOW-WCQYABFASA-N | ||
| Standard InChI | InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | (3S,4S)-Tofacitinib is the S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM. |
(3S,4S)-Tofacitinib Dilution Calculator
(3S,4S)-Tofacitinib Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2013 mL | 16.0067 mL | 32.0133 mL | 64.0266 mL | 80.0333 mL |
| 5 mM | 0.6403 mL | 3.2013 mL | 6.4027 mL | 12.8053 mL | 16.0067 mL |
| 10 mM | 0.3201 mL | 1.6007 mL | 3.2013 mL | 6.4027 mL | 8.0033 mL |
| 50 mM | 0.064 mL | 0.3201 mL | 0.6403 mL | 1.2805 mL | 1.6007 mL |
| 100 mM | 0.032 mL | 0.1601 mL | 0.3201 mL | 0.6403 mL | 0.8003 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tasocitinib also known as CP690550 is an JAK kinase inhibitor. An IC50 estimated at 0.2 μM for PV patient progenitor cells.
Featured Products
- (3R,4S)-Tofacitinib
Catalog No.:BCC4268
CAS No.:1092578-46-5
- Paxiphylline E
Catalog No.:BCN5886
CAS No.:1092555-03-7
- Paxiphylline D
Catalog No.:BCN5885
CAS No.:1092555-02-6
- Deuterated Atazanivir-D3-1
Catalog No.:BCC2115
CAS No.:1092540-56-1
- Deuterated Atazanivir-D3-3
Catalog No.:BCC2117
CAS No.:1092540-52-7
- Deuterated Atazanivir-D3-2
Catalog No.:BCC2116
CAS No.:1092540-51-6
- NVP-BSK805
Catalog No.:BCC1815
CAS No.:1092499-93-8
- BS-181
Catalog No.:BCC1439
CAS No.:1092443-52-1
- 3Beta-Isodihydrocadambine 4-oxide
Catalog No.:BCN3651
CAS No.:1092371-18-0
- Poziotinib
Catalog No.:BCC6380
CAS No.:1092364-38-9
- PP242
Catalog No.:BCC3682
CAS No.:1092351-67-1
- PSB 603
Catalog No.:BCC7598
CAS No.:1092351-10-4
New Products
- (3S,4R)-Tofacitinib
Catalog No.:BCC4267
CAS No.:1092578-48-7
- WAY 100635 hydrochloride
Catalog No.:BCC5061
CAS No.:146714-97-8
- IT1t dihydrochloride
Catalog No.:BCC6234
CAS No.:1092776-63-0
- PP121
Catalog No.:BCC4980
CAS No.:1092788-83-4
- Ruxolitinib sulfate
Catalog No.:BCC1913
CAS No.:1092939-16-6
- Ruxolitinib phosphate
Catalog No.:BCC1912
CAS No.:1092939-17-7
- 7,2',4'-Trihydroxy-5-methoxy-3-phenylcoumarin
Catalog No.:BCN1626
CAS No.:1092952-62-9
- Angelol M
Catalog No.:BCN8271
CAS No.:1092952-64-1
- PLpro inhibitor
Catalog No.:BCC5302
CAS No.:1093070-14-4
- B-Raf inhibitor 1
Catalog No.:BCC4182
CAS No.:1093100-40-3
- HNGF6A
Catalog No.:BCC8021
CAS No.:1093111-54-6
- 3-Hydroxy-4,15-dinor-1(5)-xanthen-12,8-olide
Catalog No.:BCN1625
CAS No.:1093207-99-8
Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-y l)-3-oxopropanenitrile (CP-690,550).[Pubmed:19053756]
J Med Chem. 2008 Dec 25;51(24):8012-8.
Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles.
(3S,4S)-Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
(3S,4S)-Tofacitinib,1092578-47-6,Natural Products,JAK, buy (3S,4S)-Tofacitinib , (3S,4S)-Tofacitinib supplier , purchase (3S,4S)-Tofacitinib , (3S,4S)-Tofacitinib cost , (3S,4S)-Tofacitinib manufacturer , order (3S,4S)-Tofacitinib , high purity (3S,4S)-Tofacitinib
